Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€45.60

€45.60

1.110%
0.5
1.110%
-
 
18:30 / Tradegate WKN: A2YNT3 / Name: AlzChem / Stock / Software & IT Services / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

AlzChem Group AG Stock

There is an upward development for AlzChem Group AG compared to yesterday, with an increase of €0.50 (1.110%).
For the coming years our community has positive and negative things to say abot the AlzChem Group AG stock. Criterium "Revenue growth" gathered the most positive votes but regarding "General Risks" there were negative voices in the community.

Pros and Cons of AlzChem Group AG in the next few years

Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of AlzChem Group AG vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
AlzChem Group AG 1.110% -3.219% 32.647% 135.509% 72.137% 74.806% -
Allgeier SE 0.510% 6.233% 2.833% -28.597% -8.411% -19.342% -26.866%
All For One Steeb AG 1.340% 1.017% 5.674% 42.926% 25.474% -4.180% 16.406%
CENIT AG -1.550% 1.575% 1.976% -13.131% 7.500% -10.105% -6.182%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-04-18

Looking at the financials of AlzChem, a company in the Software & IT Services industry, one can observe a positive trend in the company's growth. Net income and total assets have gradually increased over the past three years, which is generally a positive sign. However, a closer examination of various financial aspects is necessary for a comprehensive analysis.

*Pros: *

Growth in total assets: The total assets for AlzChem have experienced consistent growth over the last three years, from €354.3 million in 2020 to €422.8 million in 2022. This growth reflects an improvement in the company's overall financial health.

Comments

systinvest hat das Wertpapier AlzChem Group AG in seinem Wikifolio Aktienwertselektion mit System gekauft.
Show more

News

EQS-Adhoc: Alzchem Group AG: Alzchem Group AG receives EUR 34.4 million in EU funding
EQS-Adhoc: Alzchem Group AG: Alzchem Group AG receives EUR 34.4 million in EU funding
EQS-Adhoc: Alzchem Group AG: Alzchem Group AG receives EUR 34.4 million in EU funding
Crearene AG and Alzchem Group AG: Successful addition of creatine to dialysis patient treatments
Crearene AG and Alzchem Group AG: Successful addition of creatine to dialysis patient treatments
Crearene AG and Alzchem Group AG: Successful addition of creatine to dialysis patient treatments
EQS-News: Alzchem Group AG: EBITDA increase of 32.4 % to EUR 81.4 million – continuing on the road to success
EQS-News: Alzchem Group AG: EBITDA increase of 32.4 % to EUR 81.4 million – continuing on the road to success
EQS-News: Alzchem Group AG: EBITDA increase of 32.4 % to EUR 81.4 million – continuing on the road to success